Tonix Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Tonix Pharmaceuticals M&A Summary

Tonix Pharmaceuticals has acquired 2 companies, including 2 in the last 5 years.

Tonix Pharmaceuticals has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Tonix Pharmaceuticals Business Overview

Where is Tonix Pharmaceuticals headquartered?

Tonix Pharmaceuticals is headquartered in Chatham, New York.

How many employees does Tonix Pharmaceuticals have?

Tonix Pharmaceuticals has 103 employees.

What sector is Tonix Pharmaceuticals in?

Tonix Pharmaceuticals is a life science company.

When was Tonix Pharmaceuticals founded?

Tonix Pharmaceuticals was founded in 2007.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

Tonix Pharmaceuticals

Tonix Pharmaceuticals Holding Corp.

26 Main Street, Suite 101,
Chatham, New York 07928
United States,
(212) 980-9155
www.tonixpharma.com

Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing drugs and biologics to treat and prevent human disease and alleviate suffering. Tonix’s current portfolio includes biologics to prevent infectious diseases, and small molecules and biologics to treat pain, psychiatric and addiction conditions. In 2020, Tonix announced a program to develop a potential vaccine, TNX-1800* (live modified horsepox virus vaccine for percutaneous administration) to protect against the novel coronavirus disease emerging in 2019, or COVID-19. TNX-1800 is based on Tonix’s proprietary horsepox vaccine platform and is molecularly designed to express the Spike protein of the SARS-CoV-2 virus that causes COVID-19. TNX-801* (live horsepox virus vaccine for percutaneous administration) is in development to protect against smallpox and monkeypox. Tonix Pharmaceuticals was founded in 2007 and is based in Chatham, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - 1 - - 1 - 2
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Healion Bio - Preclinical Infectious Disease Portfolio 2023-02-02 - Divestiture
Frederick, Maryland
Trigemina, Inc. - Non-Addictive Migraine and Pain Treatment Programs 2020-06-11 - Divestiture
, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) - - -
Total 2 - - -

By Geo

State/Country Buy Value Sell Value
United States 2 - - -
  Maryland 1 - - -
  California 1 - - -
Total 2 - - -

M&A Connections

Deals
Acquired from
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.